Cargando…

National sex- and age-specific burden of blindness and vision impairment by cause in Mexico in 2019: a secondary analysis of the Global Burden of Disease Study 2019

BACKGROUND: Reliable national estimations for blindness and vision impairment are fundamental to assessing their burden and developing public health policies. However, no comprehensive analysis is available for Mexico. Therefore, in this observational study we describe the national burden of blindne...

Descripción completa

Detalles Bibliográficos
Autores principales: Madueña-Angulo, Sofia E., Beltran-Ontiveros, Saul A., Leal-Leon, Emir, Contreras-Gutierrez, Jose A., Lizarraga-Verdugo, Erik, Gutierrez-Arzapalo, Perla Y., Lizarraga-Velarde, Silvia, Romo-Garcia, Efrain, Montero-Vela, Jesus, Moreno-Ortiz, Jose M., Garcia-Magallanes, Noemi, Cuen-Diaz, Hector M., Magaña-Gomez, Javier, Velazquez, Diana Z., Hernandez-Carreño, Pavel E., Jimenez-Trejo, Francisco, Reyes, Mariana, Muñiz, Frida P., Diaz, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339251/
https://www.ncbi.nlm.nih.gov/pubmed/37457139
http://dx.doi.org/10.1016/j.lana.2023.100552
_version_ 1785071808859340800
author Madueña-Angulo, Sofia E.
Beltran-Ontiveros, Saul A.
Leal-Leon, Emir
Contreras-Gutierrez, Jose A.
Lizarraga-Verdugo, Erik
Gutierrez-Arzapalo, Perla Y.
Lizarraga-Velarde, Silvia
Romo-Garcia, Efrain
Montero-Vela, Jesus
Moreno-Ortiz, Jose M.
Garcia-Magallanes, Noemi
Cuen-Diaz, Hector M.
Magaña-Gomez, Javier
Velazquez, Diana Z.
Hernandez-Carreño, Pavel E.
Jimenez-Trejo, Francisco
Reyes, Mariana
Muñiz, Frida P.
Diaz, Daniel
author_facet Madueña-Angulo, Sofia E.
Beltran-Ontiveros, Saul A.
Leal-Leon, Emir
Contreras-Gutierrez, Jose A.
Lizarraga-Verdugo, Erik
Gutierrez-Arzapalo, Perla Y.
Lizarraga-Velarde, Silvia
Romo-Garcia, Efrain
Montero-Vela, Jesus
Moreno-Ortiz, Jose M.
Garcia-Magallanes, Noemi
Cuen-Diaz, Hector M.
Magaña-Gomez, Javier
Velazquez, Diana Z.
Hernandez-Carreño, Pavel E.
Jimenez-Trejo, Francisco
Reyes, Mariana
Muñiz, Frida P.
Diaz, Daniel
author_sort Madueña-Angulo, Sofia E.
collection PubMed
description BACKGROUND: Reliable national estimations for blindness and vision impairment are fundamental to assessing their burden and developing public health policies. However, no comprehensive analysis is available for Mexico. Therefore, in this observational study we describe the national burden of blindness and vision loss by cause and severity during 2019. METHODS: Using public data from the Global Burden of Disease (GBD) study 2019, we present national prevalence and years lived with disability (YLDs) counts and crude and age-standardized rates (per 100,000 people) of total, severity- and cause-specific blindness and vision impairment with 95% uncertainty intervals (UIs) by sex and age group. FINDINGS: In Mexico, the burden of blindness and vision impairment was estimated at 11.01 million (95% UI, 9.25–13.11) prevalent cases and 384.96 thousand (259.57–544.24) YLDs during 2019. Uncorrected presbyopia caused the highest burden (6.06 million cases, 4.36–8.08), whereas severe vision loss and blindness affected 619.40 thousand (539.40–717.73) and 513.84 thousand (450.59–570.98) people, respectively. Near vision loss and refraction disorders caused 78.7% of the cases, whereas neonatal disorders and age-related macular degeneration were among the least frequent. Refraction disorders were the main cause of moderate and severe vision loss (61.44 and 35.43%), and cataracts were the second most frequent cause of blindness (26.73%). Females suffered an overall higher burden of blindness and vision impairment (54.99% and 52.85% of the total cases and YLDs), and people >50 years of age suffered the highest burden, with people between 70 and 74 years being the most affected. INTERPRETATION: Vision loss represents a public health problem in Mexico, with women and older people being the most affected. Although the causes of vision loss contribute differentially to the severity of visual impairment, most of the impairment is avoidable. Consequently, a concerted effort at different levels is needed to alleviate this burden. FUNDING: This study received no funding.
format Online
Article
Text
id pubmed-10339251
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103392512023-07-14 National sex- and age-specific burden of blindness and vision impairment by cause in Mexico in 2019: a secondary analysis of the Global Burden of Disease Study 2019 Madueña-Angulo, Sofia E. Beltran-Ontiveros, Saul A. Leal-Leon, Emir Contreras-Gutierrez, Jose A. Lizarraga-Verdugo, Erik Gutierrez-Arzapalo, Perla Y. Lizarraga-Velarde, Silvia Romo-Garcia, Efrain Montero-Vela, Jesus Moreno-Ortiz, Jose M. Garcia-Magallanes, Noemi Cuen-Diaz, Hector M. Magaña-Gomez, Javier Velazquez, Diana Z. Hernandez-Carreño, Pavel E. Jimenez-Trejo, Francisco Reyes, Mariana Muñiz, Frida P. Diaz, Daniel Lancet Reg Health Am Articles BACKGROUND: Reliable national estimations for blindness and vision impairment are fundamental to assessing their burden and developing public health policies. However, no comprehensive analysis is available for Mexico. Therefore, in this observational study we describe the national burden of blindness and vision loss by cause and severity during 2019. METHODS: Using public data from the Global Burden of Disease (GBD) study 2019, we present national prevalence and years lived with disability (YLDs) counts and crude and age-standardized rates (per 100,000 people) of total, severity- and cause-specific blindness and vision impairment with 95% uncertainty intervals (UIs) by sex and age group. FINDINGS: In Mexico, the burden of blindness and vision impairment was estimated at 11.01 million (95% UI, 9.25–13.11) prevalent cases and 384.96 thousand (259.57–544.24) YLDs during 2019. Uncorrected presbyopia caused the highest burden (6.06 million cases, 4.36–8.08), whereas severe vision loss and blindness affected 619.40 thousand (539.40–717.73) and 513.84 thousand (450.59–570.98) people, respectively. Near vision loss and refraction disorders caused 78.7% of the cases, whereas neonatal disorders and age-related macular degeneration were among the least frequent. Refraction disorders were the main cause of moderate and severe vision loss (61.44 and 35.43%), and cataracts were the second most frequent cause of blindness (26.73%). Females suffered an overall higher burden of blindness and vision impairment (54.99% and 52.85% of the total cases and YLDs), and people >50 years of age suffered the highest burden, with people between 70 and 74 years being the most affected. INTERPRETATION: Vision loss represents a public health problem in Mexico, with women and older people being the most affected. Although the causes of vision loss contribute differentially to the severity of visual impairment, most of the impairment is avoidable. Consequently, a concerted effort at different levels is needed to alleviate this burden. FUNDING: This study received no funding. Elsevier 2023-07-11 /pmc/articles/PMC10339251/ /pubmed/37457139 http://dx.doi.org/10.1016/j.lana.2023.100552 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Madueña-Angulo, Sofia E.
Beltran-Ontiveros, Saul A.
Leal-Leon, Emir
Contreras-Gutierrez, Jose A.
Lizarraga-Verdugo, Erik
Gutierrez-Arzapalo, Perla Y.
Lizarraga-Velarde, Silvia
Romo-Garcia, Efrain
Montero-Vela, Jesus
Moreno-Ortiz, Jose M.
Garcia-Magallanes, Noemi
Cuen-Diaz, Hector M.
Magaña-Gomez, Javier
Velazquez, Diana Z.
Hernandez-Carreño, Pavel E.
Jimenez-Trejo, Francisco
Reyes, Mariana
Muñiz, Frida P.
Diaz, Daniel
National sex- and age-specific burden of blindness and vision impairment by cause in Mexico in 2019: a secondary analysis of the Global Burden of Disease Study 2019
title National sex- and age-specific burden of blindness and vision impairment by cause in Mexico in 2019: a secondary analysis of the Global Burden of Disease Study 2019
title_full National sex- and age-specific burden of blindness and vision impairment by cause in Mexico in 2019: a secondary analysis of the Global Burden of Disease Study 2019
title_fullStr National sex- and age-specific burden of blindness and vision impairment by cause in Mexico in 2019: a secondary analysis of the Global Burden of Disease Study 2019
title_full_unstemmed National sex- and age-specific burden of blindness and vision impairment by cause in Mexico in 2019: a secondary analysis of the Global Burden of Disease Study 2019
title_short National sex- and age-specific burden of blindness and vision impairment by cause in Mexico in 2019: a secondary analysis of the Global Burden of Disease Study 2019
title_sort national sex- and age-specific burden of blindness and vision impairment by cause in mexico in 2019: a secondary analysis of the global burden of disease study 2019
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339251/
https://www.ncbi.nlm.nih.gov/pubmed/37457139
http://dx.doi.org/10.1016/j.lana.2023.100552
work_keys_str_mv AT maduenaangulosofiae nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT beltranontiverossaula nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT lealleonemir nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT contrerasgutierrezjosea nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT lizarragaverdugoerik nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT gutierrezarzapaloperlay nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT lizarragavelardesilvia nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT romogarciaefrain nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT monterovelajesus nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT morenoortizjosem nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT garciamagallanesnoemi nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT cuendiazhectorm nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT maganagomezjavier nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT velazquezdianaz nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT hernandezcarrenopavele nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT jimeneztrejofrancisco nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT reyesmariana nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT munizfridap nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019
AT diazdaniel nationalsexandagespecificburdenofblindnessandvisionimpairmentbycauseinmexicoin2019asecondaryanalysisoftheglobalburdenofdiseasestudy2019